CDKN2A and neoplasm: The differential analysis also confirmed the high expression of CD74, HLA-DRA, C7, CCL12, and CCR3 in CAFs from P-LN but lower expression of VIM, APOD, MMP11, TAGLN, and CDKN2A compared with that in the primary tumor (Figure 5G; Supplementary Table S1).